Testing effectiveness (Phase 2)Study completedNCT04775953
What this trial is testing
DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia
Who this might be right for
Staphylococcal Bacteraemia
National Institute of Allergy and Infectious Diseases (NIAID) 200